Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population-Reference-Cited by-同舟云学术

Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population

Published:2021-10 Issue:5 Volume:88 Page:105186
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Wu Sifan,Kong Xiufang,Cui Xiaomeng,Chen Huiyong,Ma Lili,Dai Xiaomin,Ji Zongfei,Yan Yan,Huang Qingrong,Sun Ying,Jiang Lindi

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Rheumatology

Reference45 articles.

1. New insights on the pathogenesis of Takayasu arteritis: revisiting the microbial theory;Espinoza Jl;Pathogens (Basel, Switzerland),2018

2. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides;Jennette;Arthritis Rheum,2013

3. Updates in pathophysiology, diagnosis and management of Takayasu arteritis;Serra;Ann Vasc Surg,2016

4. Pathology of Takayasu arteritis: a brief review;Vaideeswar;Ann Pediatr Cardiol,2013

5. Gender differences in clinical presentation and vascular pattern in patients with Takayasu arteritis;Tomelleri;Scand J Rheumatol,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of tocilizumab without high-dose Glucocorticoids in patients with active Takayasu arteritis：a single center observational study;2024-02-21

2. Progress in Clinical Diagnosis and Treatment of Multiple Aortitis;Advances in Clinical Medicine;2024

3. Comprehensive Management of Takayasu Arteritis Using Immunologic and Antithrombotic Interventions With Cerebral Circulation Support: A Case Report;Cureus;2023-09-12

4. Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study;Rheumatology;2023-08-04

5. High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study;Arthritis Research & Therapy;2023-08-02